Channing Global Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.32M | Buy |
|
|||||
|
2025
Q2 | $1.05M | Buy |
|
|||||
|
2025
Q1 | $743K | Buy |
|
|||||
|
2024
Q4 | $354K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $48.4K | Sell |
|
|||||
|
2023
Q1 | $95.6K | Hold |
|
|||||
|
2022
Q4 | $81.3K | Buy |
|
|||||
|
2022
Q3 | $23K | Hold |
|
|||||
|
2022
Q2 | $26K | Hold |
|
|||||
|
2022
Q1 | $26K | Sell |
|
|||||
|
2021
Q4 | $231K | Buy |
|